IL-17 Production Is Dominated by T Cells rather than CD4
T Cells during Mycobacterium tuberculosis Infection
1
Euan Lockhart, Angela M. Green, and JoAnne L. Flynn
2
IL-17 is a cytokine produced by T cells in response to IL-23. Recent data support a new subset of CD4 Th cells distinct from Th1
or Th2 cells that produce IL-17 and may contribute to inflammation. In this study, we demonstrate that, in naive mice, as well as
during Mycobacterium tuberculosis infection, IL-17 production is primarily from T cells and other non-CD4
CD8
cells, rather
than CD4 T cells. The production of IL-17 by these cells is stimulated by IL-23 alone, and strongly induced by the cytokines,
including IL-23, produced by M. tuberculosis-infected dendritic cells. IL-23 is present in the lungs early in infection and the
IL-17-producing cells, such as T cells, may represent a central innate protective response to pulmonary infection. The Journal
of Immunology, 2006, 177: 4662– 4669.
I
nterleukin-23 is a member of the IL-12 family of cytokines
and shares the IL-12p40 subunit with IL-12. IL-23 appears to
be a driving force in chronic inflammatory disease. This cy-
tokine promotes T cell production of IL-17A, IL-17F, TNF, and
IL-6, which drive inflammation in experimental autoimmune en-
cephalomyelitis (1). IL-23 also promotes IL-17-mediated chronic
inflammation in collagen-induced arthritis (2). The profile of T cell
genes induced by IL-23 is mostly distinct from that induced by
IL-12, and IL-23 does not significantly prime for high IFN- pro-
duction in mice (1, 3). A new subset of CD4 helper cells, distinct
from that of Th1 and Th2 cells, termed Th17, has been described
(4, 5). The development of this IL-17-producing subset is inhibited
by IFN- or IL-4, and may be involved in autoimmune diseases.
However, mature Th17 cells are resistant to the effects of IL-4 and
IFN-, and are able to secrete IL-17 in Th1 or Th2 environments
(4). Overexpression of IL-17 in lung epithelium results in lung
pathology including epithelial hypertrophy and the presence of
multinucleated macrophages in the parenchyma (5).
IL-23 induction of IL-17 in the lung leads to downstream events
that mobilize cell infiltration. IL-17 induces chemokines, growth
factors, and adhesion molecules, and augments neutrophil accu-
mulation (6, 7). It has been demonstrated to play a role in control
of pulmonary infection due to Klebsiella, an extracellular bacterial
pathogen, in mouse models.
There are several lines of evidence that suggest cells con-
tribute to the immune response to Mycobacterium tuberculosis.
In the macaque model of infection with Mycobacterium bovis
bacillus Calmette-Gue ´rin (BCG),
3
the V2V2
T cell subset
expand rapidly during primary exposure and also to secondary
challenge with BCG or virulent M. tuberculosis (8). Similarly,
intranasal infection of mice expanded resident V2 T cells and
caused an influx of other subsets into the lung. These cells
were capable of producing IFN- and were cytotoxic toward
infected macrophages in vitro (9). In humans, cells from
BCG-vaccinated individuals expand upon restimulation with
mycobacterial Ag, thereby displaying a memory-like phenotype
(10). Human alveolar macrophages infected with M. tubercu-
losis release chemoattractants such as CXCL10 that cause che-
motaxis of cells and cytokine secretion (11). These chemoat-
tractants are found in the lungs and axillary lymph nodes of
patients with active disease. In the mouse model of M. tuber-
culosis infection, knockout (KO) mice have a more pyogenic
granulomatous response, implying a regulatory role in granu-
loma formation (12).
IL-12 has a central role in priming T cells to produce IFN- in
response to M. tuberculosis (13, 14). IL-23 also contributes to
resistance as suggested by the increased susceptibility of IL-
12p40
/
compared with IL-12p35
/
mice during experimental
infection (15). Somewhat surprisingly in light of that study, mice
deficient in the p19 subunit of IL-23 did not display obviously
increased susceptibility to M. tuberculosis (as measured by bacte-
rial numbers). The relatively less susceptible phenotype of IL-
12p35
/
mice may be due to the fact that IL-23 can also make a
minor contribution to IFN- production in the absence of IL-12
(16). It was also demonstrated that IL-23 is an absolute require-
ment in CD4
T cell production of IL-17 during M. tuberculosis
infection (16). The role of the IL-17-producing T cells in control
of M. tuberculosis infection is not known.
In this study, we have used murine M. tuberculosis infection as
a model to investigate the interaction between IL-23 and IL-17,
with particular emphasis on the cells that respond to IL-23. By
using a slow growing bacterium against which immune responses
develop slowly, we have dissected the early IL-17 responses in the
lungs, and the chronicity of cytokine production.
Recently, a homeostatic loop involving IL-23-induced IL-17
production by unconventional T cells and cells has been
described (17). Whereas IL-23 and IL-17 promote granulopoiesis
and influx of neutrophils into the lung, phagocytosis of apoptotic
lung neutrophils reduces macrophage IL-23 secretion, and induc-
tion of IL-17, thereby limiting influx. The data presented here sim-
ilarly demonstrate that, in naive mice, IL-17 production can be
induced in T cells. However, our study also demonstrates that
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School
of Medicine, Pittsburgh, PA 15261
Received for publication April 26, 2006. Accepted for publication July 14, 2006.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1
This work was supported by National Institutes of Health Grants RO1 AI50732 and
AI37859 (to J.L.F.), T32 CA82084-07 (to E.L.), and AI060525 (to A.M.G.) and C
Advisors Grant.
2
Address correspondence and reprint requests to Dr. JoAnne L. Flynn, W1157 Bio-
medical Science Tower, Pittsburgh, PA 15261. E-mail address: joanne@pitt.edu
3
Abbreviations used in this paper: BCG, bacillus Calmette-Gue ´rin; KO, knockout;
DC, dendritic cell.
The Journal of Immunology
Copyright © 2006 by The American Association of Immunologists, Inc. 0022-1767/06/$02.00